SkinMedica Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:SkinMedica Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3458
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
SkinMedica Inc (SkinMedica), a subsidiary of Allergan Plc, is a skin care service provider. The company offers cleanse, correct, moisturize and hydrate, protect, brighten, targeted treatments and professional peels among others. It provides essential serum, rejuvenating hydrator, total defence and repair, skin brightening complex and recovery complex, among others. SkinMedica gels for the treatment of mild to moderate atopic dermatitis creams for the reduction in growth of unwanted facial hair in women. The company offers products for treatment of hyper pigmentation. It markets products through physicians’ offices and online. SkinMedica is headquartered in Carlsbad, California, the US.

SkinMedica Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
SkinMedica Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SkinMedica Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SkinMedica Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SkinMedica Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
SkinMedica Inc, Medical Devices Deals, 2012 to YTD 2018 9
SkinMedica Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
SkinMedica Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Colorescience Raises USD15 Million in Series B Venture Financing 11
Colorescience Raises US$10 Million In Series A Financing 12
Colorescience Raises US$15 Million In Venture Financing 13
SkinMedica Raises US$16.8 Million In Venture Financing 14
Partnerships 15
Skinmedica Enters Into R&D Agreement With Massachusetts General Hospital 15
Acquisition 16
Allergan Completes Acquisition Of SkinMedica, Skin Products Maker, For US$350 Million 16
SkinMedica Acquires Colorescience, Maker Of Skincare Products 18
SkinMedica Inc – Key Competitors 19
SkinMedica Inc – Key Employees 20
SkinMedica Inc – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
SkinMedica Inc, Pharmaceuticals & Healthcare, Key Facts 2
SkinMedica Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SkinMedica Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SkinMedica Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SkinMedica Inc, Deals By Therapy Area, 2012 to YTD 2018 8
SkinMedica Inc, Medical Devices Deals, 2012 to YTD 2018 9
SkinMedica Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Colorescience Raises USD15 Million in Series B Venture Financing 11
Colorescience Raises US$10 Million In Series A Financing 12
Colorescience Raises US$15 Million In Venture Financing 13
SkinMedica Raises US$16.8 Million In Venture Financing 14
Skinmedica Enters Into R&D Agreement With Massachusetts General Hospital 15
Allergan Completes Acquisition Of SkinMedica, Skin Products Maker, For US$350 Million 16
SkinMedica Acquires Colorescience, Maker Of Skincare Products 18
SkinMedica Inc, Key Competitors 19
SkinMedica Inc, Key Employees 20
SkinMedica Inc, Subsidiaries 21

List of Figures
SkinMedica Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
SkinMedica Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
SkinMedica Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
SkinMedica Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
SkinMedica Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SkinMedica Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
SkinMedica Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SkinMedica Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
SkinMedica Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[SkinMedica Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Aldi Einkauf GmbH & Co oHG:企業の戦略・SWOT・財務分析
    Aldi Einkauf GmbH & Co oHG - Strategy, SWOT and Corporate Finance Report Summary Aldi Einkauf GmbH & Co oHG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Symrise AG (SY1):企業の財務・戦略的SWOT分析
    Symrise AG (SY1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Qantas Airways Ltd (QAN):企業の財務・戦略的SWOT分析
    Qantas Airways Ltd (QAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • United International Enterprises Limited:企業の戦略・SWOT・財務分析
    United International Enterprises Limited - Strategy, SWOT and Corporate Finance Report Summary United International Enterprises Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Asseco Business Solutions SA (ABS):企業の財務・戦略的SWOT分析
    Asseco Business Solutions SA (ABS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Aprecia Pharmaceuticals Company:製薬・医療:M&Aディール及び事業提携情報
    Summary Aprecia Pharmaceuticals Company (Aprecia) is a drug delivery technology platform company that develops pharmaceutical drug products. The company offers Zipdose technology, a delivery platform that serves as the foundation of orodispersible formulations of prescribed high-dose medications. It …
  • Lockheed Martin Aeronautics Company:企業の戦略・SWOT・財務分析
    Lockheed Martin Aeronautics Company - Strategy, SWOT and Corporate Finance Report Summary Lockheed Martin Aeronautics Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Calix Ltd (CXL):企業の財務・戦略的SWOT分析
    Calix Ltd (CXL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Bhansali Engineering Polymers Ltd (BEPL):企業の財務・戦略的SWOT分析
    Summary Bhansali Engineering Polymers Ltd (BEPL), formerly Bhansali Steel Ltd is a petrochemical company that manufactures and markets acrylonitrile butadiene styrene. The company's products include general ABS, extrusion ABS, flame retardant ABS, ABS-GF or SAN-GF, PMMA-ABS, PVC modifier, PC or ABS …
  • Ficosa International SA:企業の戦略・SWOT・財務情報
    Ficosa International SA - Strategy, SWOT and Corporate Finance Report Summary Ficosa International SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Greenergy International Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Greenergy International Ltd (GIL) is an energy company that sells petroleum products. The company’s products include petrol, diesel, biodiesel, ultra-low sulphur gasoil, bioethanol, kerosene and ULSG. It offers manufacturing and infrastructure, fuel supply, infrastructure investment, biofuel …
  • Adaptimmune Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Adaptimmune Ltd (Adaptimmune), a subsidiary of Adaptimmune Therapeutics Plc is a clinical stage biotechnology company that develops T-cell therapy products for the treatment of cancer. The company’s pipeline peptides include NY-ESO TCR used to treat cancer cells, MAGE A-10 TCR used for the t …
  • SINTEF:企業の戦略的SWOT分析
    SINTEF - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Beerenberg Corp AS:企業の戦略的SWOT分析
    Beerenberg Corp AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Telefonica, S.A.:企業の戦略・SWOT・財務情報
    Telefonica, S.A. - Strategy, SWOT and Corporate Finance Report Summary Telefonica, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Turkiye IS Bankasi A.S.:戦略・SWOT・企業財務分析
    Turkiye IS Bankasi A.S. - Strategy, SWOT and Corporate Finance Report Summary Turkiye IS Bankasi A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Golden Dawn Minerals Inc (GOM):企業の財務・戦略的SWOT分析
    Summary Golden Dawn Minerals Inc (Golden Dawn) is a mining and mineral exploration and development company. it offers acquisition, exploration, operations, management, production, and development of gold, uranium, silver, iron, lead, zinc, base metals, precious metals, and mineral resource deposit p …
  • Chong Kun Dang Pharmaceutical Corp (185750):製薬・医療:M&Aディール及び事業提携情報
    Summary Chong Kun Dang Pharmaceutical Corp (CKD Pharma) manufactures, distributes, imports and exports prescription drugs, active pharmaceutical ingredients (APIs), over-the-counter (OTC) drugs, health supplements and consumer health products. Its product portfolio includes prescription products for …
  • B3 S.A.
    B3 S.A. - Strategy, SWOT and Corporate Finance Report Summary B3 S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Allgeier SE (AEIN):企業の財務・戦略的SWOT分析
    Allgeier SE (AEIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆